4//SEC Filing
Doman Robert F 4
Accession 0001415889-13-000710
CIK 0001031927other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:50 PM ET
Size
5.6 KB
Accession
0001415889-13-000710
Insider Transaction Report
Form 4
Doman Robert F
Director
Transactions
- Award
Common Stock
2013-04-09+4,000→ 39,000 total
Footnotes (1)
- [F1]The shares vest on April 9, 2014, provided, however that all unvested Restricted Shares shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days ; or (d) or a combination of cash and the foregoing securities
Documents
Issuer
Echo Therapeutics, Inc.
CIK 0001031927
Entity typeother
Related Parties
1- filerCIK 0001313163
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:50 PM ET
- Size
- 5.6 KB